Tetsuya Kimura Selected Research

Biomarkers (Surrogate Marker)

8/2023	Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Subcohort Study.
1/2022	D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
1/2022	Catheter Ablation Energy Sources and Myocardial Injury and Coagulation Biomarkers During Uninterrupted Periprocedural Edoxaban Use　- A Subanalysis of KYU-RABLE.
2/2021	Changes in plasma concentrations of edoxaban and coagulation biomarkers according to thromboembolic risk and atrial fibrillation type in patients undergoing catheter ablation: Subanalysis of KYU-RABLE.
1/2016	Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuya Kimura Research Topics

Disease

46	Atrial Fibrillation 01/2024 - 01/2015
33	Hemorrhage 01/2024 - 06/2014
20	Stroke (Strokes) 01/2024 - 01/2015
8	Ischemic Stroke 10/2023 - 12/2019
7	Heart Failure 01/2024 - 06/2019
6	Neoplasms (Cancer) 11/2023 - 06/2012
5	Embolism (Embolus) 01/2024 - 01/2016
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 01/2016
5	Alzheimer Disease (Alzheimer's Disease) 12/2015 - 02/2006
4	Tauopathies 12/2015 - 02/2012
4	Inflammation (Inflammations) 06/2012 - 04/2003
3	Dementia (Dementias) 11/2023 - 03/2005
3	Body Weight (Weight, Body) 11/2022 - 01/2016
3	Venous Thromboembolism 01/2016 - 01/2015
3	Infections 05/2009 - 01/2002
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2023 - 01/2009
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2023 - 07/2009
2	Chronic Renal Insufficiency 10/2020 - 02/2009
2	Transient Ischemic Attack 01/2020 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2017 - 01/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 11/2012
2	Starvation 10/2016 - 01/2005
2	Ischemia 07/2009 - 12/2006
2	Disease Progression 08/2008 - 03/2007
1	Congenital Abnormalities (Deformity) 02/2024
1	Developmental Dysplasia of the Hip 02/2024
1	Diabetes Mellitus 12/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2023
1	Lung Neoplasms (Lung Cancer) 11/2023
1	Myocardial Infarction 08/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Frailty 07/2022
1	Dermatitis 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Thromboembolism 02/2021
1	Masked Hypertension 01/2021
1	Hemorrhagic Stroke 01/2020
1	Heart Diseases (Heart Disease) 06/2019
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2019
1	Myotonia 01/2019
1	Vasculitis (Vasculitides) 08/2017
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2017
1	Knee Osteoarthritis 06/2017
1	Fatigue 06/2017
1	Idiopathic Pulmonary Fibrosis 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Idiopathic Interstitial Pneumonias 01/2017
1	Sarcoidosis (Schaumann Disease) 01/2017

Drug/Important Bio-Agent (IBA)

30	AnticoagulantsIBA 01/2024 - 01/2018
22	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 01/2015
21	edoxabanIBA 11/2023 - 06/2014
8	CreatinineIBA 11/2023 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2008
4	Enoxaparin (Lovenox)FDA LinkGeneric 01/2016 - 06/2014
3	fibrin fragment D (D-dimer)IBA 08/2023 - 01/2022
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2017 - 02/2013
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2023 - 10/2020
2	Vitamin K FDA Link 11/2023 - 10/2022
2	Heparin (Liquaemin)FDA LinkGeneric 12/2022 - 01/2018
2	Factor Xa InhibitorsIBA 01/2021 - 09/2017
2	CD100 antigenIBA 08/2017 - 06/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 08/2008
2	Semaphorins (Semaphorin)IBA 01/2013 - 02/2012
2	ChemokinesIBA 06/2012 - 04/2003
2	Antiviral Agents (Antivirals)IBA 12/2008 - 01/2002
2	Thymidine PhosphorylaseIBA 12/2006 - 01/2005
1	Capsules (Microcapsules)IBA 02/2024
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2023
1	RetinoidsIBA 01/2023
1	vinyltriethoxysilane (VTES)IBA 01/2022
1	Proton Pump InhibitorsIBA 01/2020
1	N- (5- (2- bromobenzyl)thiazole- 2- yl)benzofuran- 2- carboxamideIBA 01/2020
1	Serum AlbuminIBA 06/2019
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2019
1	Thyroid HormonesIBA 01/2019
1	TabletsIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2017
1	Volatile Oils (Essential Oils)IBA 06/2017
1	InterferonsIBA 01/2017

Therapy/Procedure

18	Therapeutics 01/2024 - 03/2007
10	Catheter Ablation 11/2023 - 01/2019
3	Polypharmacy 01/2024 - 12/2022
2	Drug Therapy (Chemotherapy) 11/2023 - 01/2023
2	Transcatheter Aortic Valve Replacement 11/2023 - 10/2022
2	Drug Tapering 01/2016 - 01/2015
2	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2016 - 01/2016
2	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2016 - 01/2015
1	Percutaneous Coronary Intervention 01/2020
1	Secondary Prevention 12/2019
1	Intra-Articular Injections 06/2017